• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吉哌隆治疗非典型抑郁症:5-羟色胺能参与的初步证据。

Gepirone treatment of atypical depression: preliminary evidence of serotonergic involvement.

作者信息

McGrath P J, Stewart J W, Quitkin F M, Wager S, Jenkins S W, Archibald D G, Stringfellow J C, Robinson D S

机构信息

Depression Evaluation Service, New York State Psychiatric Institute, NY 10032.

出版信息

J Clin Psychopharmacol. 1994 Oct;14(5):347-52.

PMID:7806692
Abstract

This is a report of a controlled trial of gepirone, a 5-hydroxytryptamine (5-HT1A) partial agonist azapirone related to buspirone, in the treatment of atypical depression. The azapirones are of particular interest because their highly selective actions on the serotonergic system may possibly make them useful pharmacologic probes and potentially selective therapeutic agents. Sixty outpatients meeting Columbia criteria for definite or probable atypical depression were enrolled in a double-blind, randomized, placebo-controlled, 8-week clinical trial at a single site. The dosage schedule was fixed flexible, with 10-mg capsules given on a thrice-daily schedule, with doses of up to 120 mg daily. The response rate at 8 weeks for the intention-to-treat sample analyzed with the last observation carried forward was 62% (18 of 29 patients) for gepirone and 20% (6 of 30 patients) for placebo (chi 2 = 9.1; df = 1; p < 0.001). Robust and consistent drug-placebo differences are seen across virtually all rating scales post-treatment. The effect of gepirone was consistent across the levels of concomitant variables, including duration of episode and presence of dysthymia or panic. Gepirone is a novel antidepressant that holds promise for the treatment of atypical depression and that may be of heuristic value because of its relatively specific actions on the serotonergic system.

摘要

这是一篇关于吉哌隆(一种与丁螺环酮相关的5-羟色胺(5-HT1A)部分激动剂氮杂螺环酮)治疗非典型抑郁症的对照试验报告。氮杂螺环酮特别引人关注,因为它们对血清素能系统具有高度选择性作用,这可能使它们成为有用的药理学探针和潜在的选择性治疗药物。60名符合哥伦比亚明确或可能非典型抑郁症标准的门诊患者在单一地点参加了一项为期8周的双盲、随机、安慰剂对照临床试验。给药方案为固定灵活给药,10毫克胶囊每日三次给药,每日剂量最高可达120毫克。采用末次观察结转法分析意向性治疗样本,8周时吉哌隆的有效率为62%(29例患者中的18例),安慰剂为20%(30例患者中的6例)(卡方 = 9.1;自由度 = 1;p < 0.001)。治疗后几乎所有评分量表上都出现了显著且一致的药物与安慰剂差异。吉哌隆的疗效在伴随变量的各个水平上都是一致的,包括发作持续时间以及是否存在心境恶劣或惊恐症状。吉哌隆是一种新型抗抑郁药,有望用于治疗非典型抑郁症,并且由于其对血清素能系统的相对特异性作用,可能具有启发价值。

相似文献

1
Gepirone treatment of atypical depression: preliminary evidence of serotonergic involvement.吉哌隆治疗非典型抑郁症:5-羟色胺能参与的初步证据。
J Clin Psychopharmacol. 1994 Oct;14(5):347-52.
2
Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.阿吡哌隆缓释剂治疗伴焦虑的抑郁症:来自重度抑郁症患者回顾性亚组分析的证据
J Clin Psychiatry. 2004 Aug;65(8):1069-75.
3
Gepirone extended-release: new evidence for efficacy in the treatment of major depressive disorder.戈吡酯缓释片:治疗重度抑郁症有效性的新证据。
J Clin Psychiatry. 2003 Mar;64(3):243-9.
4
A double-blind comparison of gepirone extended release, imipramine, and placebo in the treatment of outpatient major depression.在门诊重性抑郁治疗中,对缓释阿普唑仑、丙咪嗪和安慰剂进行的双盲比较。
Psychopharmacol Bull. 1996;32(4):659-65.
5
Sustained efficacy of gepirone-IR in major depressive disorder: a double-blind placebo substitution trial.长效 gepirone 在重度抑郁症中的持续疗效:一项双盲安慰剂替代试验。
J Psychiatr Res. 2004 May-Jun;38(3):259-65. doi: 10.1016/j.jpsychires.2003.10.005.
6
A double-blind trial of low- and high-dose ranges of gepirone-ER compared with placebo in the treatment of depressed outpatients.一项关于缓释盖吡咯低剂量范围和高剂量范围与安慰剂对比治疗门诊抑郁症患者的双盲试验。
Psychopharmacol Bull. 1996;32(3):335-42.
7
Gepirone as a 5-HT1A agonist in the treatment of major depression.
Psychopharmacol Bull. 1990;26(2):169-71.
8
A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression.一项关于使用哌甲酯缓释制剂对难治性抑郁症门诊患者进行增效治疗的随机、双盲、安慰剂对照试验。
J Clin Psychopharmacol. 2006 Dec;26(6):653-6. doi: 10.1097/01.jcp.0000246212.03530.fd.
9
Serotonergic anxiolytics and treatment of depression.
Psychopathology. 1989;22 Suppl 1:27-36. doi: 10.1159/000284624.
10
A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.一项关于文拉法辛缓释剂、帕罗西汀和安慰剂治疗惊恐障碍疗效的双盲研究。
Depress Anxiety. 2007;24(1):1-14. doi: 10.1002/da.20218.

引用本文的文献

1
Placebo response in neuropathic pain after spinal cord injury: a meta-analysis of individual participant data.脊髓损伤后神经性疼痛的安慰剂反应:个体参与者数据的荟萃分析
J Pain Res. 2018 Apr 30;11:901-912. doi: 10.2147/JPR.S155979. eCollection 2018.
2
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2018 Jan 15;48(1):64-153.
3
Effects of food on the bioavailability of gepirone from extended-release tablets in humans: results of two open-label crossover studies.食物对人服用缓释片后吉哌隆生物利用度的影响:两项开放标签交叉研究的结果
Curr Ther Res Clin Exp. 2003 Sep;64(8):580-98. doi: 10.1016/j.curtheres.2003.09.012.
4
Atypical depression.非典型抑郁症
Psychiatry (Edgmont). 2006 Apr;3(4):33-9.
5
Atypical depression: a comprehensive review.非典型性抑郁症:全面综述。
CNS Drugs. 2009 Dec;23(12):1023-37. doi: 10.2165/11310990-000000000-00000.
6
Olanzapine and fluoxetine combination therapy for treatment-resistant depression: review of efficacy, safety, and study design issues.奥氮平与氟西汀联用治疗难治性抑郁症:疗效、安全性及研究设计问题的综述。
Neuropsychiatr Dis Treat. 2009;5:369-83. doi: 10.2147/ndt.s5819. Epub 2009 Jul 2.
7
Antipsychotic and antidepressive effects of second generation antipsychotics: two different pharmacological mechanisms?第二代抗精神病药物的抗精神病和抗抑郁作用:两种不同的药理机制?
Eur Arch Psychiatry Clin Neurosci. 2005 Jun;255(3):190-201. doi: 10.1007/s00406-005-0587-5.
8
Future antidepressants: what is in the pipeline and what is missing?未来的抗抑郁药:正在研发的有哪些,还缺少什么?
CNS Drugs. 2004;18(11):705-32. doi: 10.2165/00023210-200418110-00002.
9
Depression With Atypical Features: Diagnostic Validity, Prevalence, and Treatment.伴有非典型特征的抑郁症:诊断效度、患病率及治疗
Prim Care Companion J Clin Psychiatry. 2002 Jun;4(3):94-99. doi: 10.4088/pcc.v04n0302.